Analyst Research

Report Title Price
Visiomed Group SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Wright Investors Service Comprehensive Report for Visiomed Group SA
Provider: Wright Reports
$380.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Visiomed Group SA to Build Breathalyzers Manufacturing Plant with Industrial Partner


Tuesday, 11 Dec 2012 12:15pm EST 

Visiomed Group SA announced its entry into French NF certified breathalyzers. The Company has been associated with an industrial partner in order to build a manufacturing plant to produce chemical disposable breathalyzers. The first deliveries have already been held in early December 2012 in the pharmacy network in France. The manufacturing unit is already sized to produce, at cruising speed, 12 million units per year. 

Latest Developments for Visiomed Group SA

Latest Key Developments in Medical

Company Quote

Visiomed Group SA
(ALVMG.PA)
2.85
-0.16 -5.32%
20 May 2013